merkel cell carcinoma

Showing 2 posts of 2 posts found.

Merck and Pfizer’s joint skin cancer drug gets EU approval

September 21, 2017
Sales and Marketing Bavencio, Cancer, Merck, Pfizer, merkel cell carcinoma, pharma, pharmaceutical, skin canceer

Merck KGaA and Pfizer have announced that European authorisation of their jointly developed drug Bavencio (avelumab) as a monotherapy in …


Pivotal avelumab data in Merkel cell carcinoma presented at ASCO

June 6, 2016
Manufacturing and Production, Research and Development ASCO, Merck, Pfizer, avelumab, merkel cell carcinoma

New data presented at the American Society of Clinical Oncology’s annual general meeting has shown that avelumab, an investigational anti-PD-L1 …

Latest content